Bollard Group LLC Elanco Animal Health Inc Transaction History

Bollard Group LLC

  • $3.54 Billion
  • Q2 2024

A detailed history of Bollard Group LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Bollard Group LLC holds 591 shares of ELAN stock, worth $8,463. This represents 0.0% of its overall portfolio holdings.

Number of Shares
591
Previous 591 -0.0%
Holding current value
$8,463
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$8.79 - $14.58 $94,378 - $156,545
-10,737 Reduced 94.78%
591 $6,000
Q4 2022

Feb 10, 2023
SELL
$11.49 - $13.65 $769 - $914
-67 Reduced 0.59%
11,328 $138,000
Q3 2022

Nov 09, 2022
SELL
$12.41 - $32.42 $62,422 - $163,072
-5,030 Reduced 30.62%
11,395 $141,000
Q2 2022

Aug 12, 2022
SELL
$19.63 - $26.62 $87,824 - $119,097
-4,474 Reduced 21.41%
16,425 $322,000
Q1 2022

May 12, 2022
BUY
$24.65 - $29.0 $18,832 - $22,156
764 Added 3.79%
20,899 $545,000
Q4 2021

Feb 11, 2022
SELL
$27.74 - $34.09 $249,770 - $306,946
-9,004 Reduced 30.9%
20,135 $571,000
Q3 2021

Nov 12, 2021
BUY
$29.2 - $36.72 $100,798 - $126,757
3,452 Added 13.44%
29,139 $929,000
Q2 2021

Aug 12, 2021
SELL
$28.76 - $35.98 $17,773 - $22,235
-618 Reduced 2.35%
25,687 $891,000
Q3 2020

Nov 12, 2020
SELL
$21.1 - $29.13 $1,329 - $1,835
-63 Reduced 0.24%
26,305 $735,000
Q1 2020

May 14, 2020
SELL
$16.68 - $32.25 $67,720 - $130,935
-4,060 Reduced 13.34%
26,368 $590,000
Q3 2019

Nov 13, 2019
SELL
$25.62 - $34.96 $34,382 - $46,916
-1,342 Reduced 4.22%
30,428 $809,000
Q2 2019

Aug 13, 2019
SELL
$31.11 - $34.79 $31 - $34
-1 Reduced -0.0%
31,770 $1.07 Million
Q1 2019

May 10, 2019
BUY
$29.0 - $32.83 $921,359 - $1.04 Million
31,771 New
31,771 $1.02 Million

Others Institutions Holding ELAN

# of Institutions
447
Shares Held
478M
Call Options Held
3.1M
Put Options Held
1.26M
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.79B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email